Skip to main content
Glenmark has managed to develop API for anti-viral drug, Favipiravir. Clinical Trials will last around 14 days to 1 month. Once the company passes through clinical trials, it can launch the drug in Indian market: Sources to @ekta_batra https://t.co/hifJxm5fwn
Popular posts from this blog